Notably, simultaneous targeting of CD47 and VEGF via VEGFR1-SIRPα fusion protein could induce infiltration of macrophages and sensitize NSCLC to antiangiogenic agents and CD47 blockade [85]. This evidence concerns the gene SIRPA and non-small cell lung carcinoma.